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ABSTRACT A number of pMB1 derivatives provide a
trans-acting function that can suppress lethal runaway replica-
tion of a temperature-sensitive copy-number mutant of NTP1.
Deletion analysis indicates that the region of the pMB1 genoane
that contains the rop gene is required for this suppression. Mu-
tant derivatives of the temperature-sensitive copy-number mu-
tant plasmid whose conditional lethal phenotype is not sup-
pressed in trans by the region-encoding the rop gene have been
isolated. These rop-insensitive derivatives contain single nucle-
otide changes within the RNA I coding region.
Initiation of replication of ColEl-type plasmids is regulated
by two trans-acting negative control elements (Fig. 1) (1-5).
One of these elements, RNA I, acts as a replicon-specific
inhibitor of plasmid replication and is responsible for plas-
mid incompatibility (2, 7, 8). Purified RNA I inhibits the
processing of a second plasmid transcript, RNAII, in vitro.
This processing is necessary to form the primer for initiation
ofDNA synthesis. The target ofRNA I inhibition is believed
to lie within a region of RNA II that is complementary to
RNAI(7, 9, 10). Both RNA I and its complementary region
on RNA II may adopt a secondary structure with three stem-
loop structures. Genetic studies indicate that the single-
strand loops are involved in the inhibitory activity of RNAI,
which occurs by base-pairing with the complementary se-
quence ofRNAII(7, 10). The hybridization of the two tran-
scripts prevents the formation of an RNA-DNA hybrid struc-
ture between RNA II and its template near the replication
origin (2). The RNA-DNA hybrid is a substrate for ribonucle-
ase H, which cleaves the transcript at the origin of replica-
tion to create the 3'-OH end of the primer (11).
The second element in the copy control system is the
product of a gene located 500 base pairs (bp) downstream
from the replication origin of ColEl arid pMB1 (3-5). Twigg
and Sherratt (3) observed that deletions of this region of
ColEl and pMB1 derivatives caused an increase in the plas-
mid copy numbers. They also showed that the elevated copy
numbers could be reduced to wild-type levels by providing
the deleted function in trans from a second compatible plas-
mid in the cell. Cesareni et al. (4) reported that in vivo
expression of the lacZ gene directed by the primer promoter
was reduced in the presence of a plasmid carrying this "re-
pressor." They proposed that the repressor is a 63 amino
acid polypeptide that is conserved in both ColEl and pMB1.
They speculated that this repressor, which they designated
rop (for repressor of primer), acted independently of RNA I
to regulate plasmid replication by limiting transcription initi-
ation of RNA II, the primer precursor.
We have observed that a ts runaway replication mutant
plasmid fails to express its conditional lethal phenotype in
the presence of certain compatible plasmids. Genetic evi-
dence suggests that this suppression is mediated by the rop
gene encoded on the second plasmid. We have taken advan-
tage of this activity of rop to select mutant derivatives of the
ts plasmid that are insensitive to rop suppression. DNA se-
quencing of a number of these rop-insensitive derivatives
provides information about the mechanism of rop-mediated
regulation of plasmid replication.
MATERIALS AND METHODS
Bacterial Strains and Plasmids. All of the transformation
and plasmid studies were carried out in Escherichia coli
HB101 pro gal hsdR hsdM recAl. Plasmid pJN75 is a 5.4-
kilobase ampicillin-resistant derivative of NTP1 (12, 13).
pJN75 exhibits a ts mutant copy-number phenotype. The
presence of the plasmid is lethal to the host cell at the restric-
tive temperature, 370C. The lethality is a result of runaway
plasmid replication. A single nucleotide difference from the
wild-type NTP1 sequence within the region required for rep-
lication appears to be responsible for the ts mutant pheno-
type (12). This mutation is a G-C to A-T transition located
398 bp upstream of the origin of DNA synthesis. Plasmid
pMB9 is a tetracycline-resistant derivative of pMB1. Other
plasmids are described in Tables 1 and 2.
Isolation of pJN75 Mutants Whose ts Runaway Replication
Phenotype Is Not Suppressed by the rop Gene Product. Tweh-
ty cultures of E. coli HB101 containing pJN75 were grown at
30°C to an A590 of 0.3 in 5 ml of L broth. Chloramphenicol
(100 ,ug/ml) and N-methyl-N'-nitro-N-nitrosoguanidine (20
Mg/ml) were added and incubation was continued overnight.
Plasmid DNA was isolated from each of the cultures used to
transform individual cultures of E. coli HB101 containing
pMB9 by the procedure of Dagert and Ehrlich (17). Cells
were spread onto L plates containing tetracycline (15 ,ug/ml)
and a high concentration of ampicillin (4 mg/ml) and incubat-
ed at 34°C overnight. Under these conditions, cells contain-
ing pJN75, which is at high copy number, survive. However,
cells containing both pJN75 and pMB9 do not form colonies
under these conditions, presumably because rop suppression
of pJN75 replication reduces the copy number of pJN75 to a
level below what is needed to confer resistance to 4 mg of
ampicillin per ml. Mutants of pJN75 that are insensitive to
the rop suppression are able to grow in the presence of
pMB9 at 34°C on 4 mg of ampicillin per ml. Several colonies
grew up from each of the 20 transformations carried out with
mutagenized DNA, whereas no colonies were obtained
when nonmutagenized DNA was used. Colonies from each
of the 20 plates were then tested for expression of the ts le-
thal phenotype by replica-plating colonies onto two sets of
plates containing tetracycline (15 ug/ml) and a low concen-
tration of ampicillin (50 ,ug/ml) and growing one set at 30°C
and the other set at 42°C overnight. Approximately 25% of
the colonies grew at 30°C but did not grow at the higher tem-
perature. Plasmid DNA was purified from seven ts colonies,
each derived from a separate mutagenized DNA to insure
independence of mutants examined.
Abbreviations: ts, temperature sensitive; bp, base pair(s).
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FIG. 1. DNA replication origin of plasmid NTP1 (RSF1030). The origin region of NTP1 has a sequence identical to that of RSF1030 (6). The
locations of the coding region for RNA I and RNA II are shown relative to the site of initiation ofDNA synthesis. This plasmid does not contain
a rop gene. The original temperature-sensitive (ts) mutation (orp) maps at -398, within the sequence for RNA II, whereas the mutations
identified in this study map at -430, -439, and -449.
DNA Sequence Analysis. The nucleotide sequence sur-
rounding the replication origin of pJN75 has been reported
(13, 14). The sequence of the origin region of seven pJN75
mutants was determined by the chemical degradation meth-
od of Maxam and Gilbert (21). Approximately 800 nucleo-
tides were sequenced, encompassing a region extending
from 700 nucleotides upstream of the origin ofDNA synthe-
sis to 100 nucleotides downstream of the origin. Some of the
sites used for sequencing are indicated in Fig. 1.
RESULTS
Suppression of pJN75 Runaway Replication by the rop Gene
Product. Plasmid pJN75 is a ts copy-number mutant deriva-
tive of plasmid NTP1. (12, 13). [Although isolated indepen-
dently, NTP1 is apparently identical to plasmid RSF1030 (6,
14, 15).] Bacteria containing pJN75 grow normally at the per-
missive temperature (30°C) but cease growth and die one or
two generations after a shift to the nonpermissive tempera-
ture (37°C). Loss of viability appears to be a consequence of
runaway replication, which results in an increase in plasmid
synthesis from about 8% of chromosomal DNA synthesis to
150% in the first 10 min after the temperature shift (13).
We have previously identified the mutation in pJN75 re-
sponsible for the ts mutant replication phenotype (12). This
mutation is a single base pair change, a G-C to A-T transition,
located 398 bp upstream of the origin of DNA synthesis (see
Fig. 1). The temperature-induced over-replication pheno-
type is most likely the consequence of thermolability of a
secondary structure within the primer precursor that is nor-
mally essential for regulation, though this has not been
shown conclusively (12, 22). The inability of this structure to
form at the restrictive temperature may render replication of
the plasmid insensitive to normal regulation through RNA I
inhibition.
We have observed that runaway replication of pJN75 at
the nonpermissive temperature is suppressed in the presence
of certain compatible plasmids. This suppression was first
observed in double transformants of pJN75 and pMB9, a tet-
racycline-resistant derivative of plasmid pMB1. The double
transformants grew normally at 42°C as well as at 30°C in the
presence of both ampicillin and tetracycline. Plasmid DNA
Table 1. Major plasmids used in these studies
Drug
Plasmid Characteristic Compatibility resistance Refs.
pJN70 Wild type RSF1030 Ampicillin 6, 14, 15
pJN75 ts RSF1030 Ampicillin 12, 13
pMB9 rop pMB1 Tetracycline 16
Other plasmids used are found in Table 2. E. coli HB101 pro gal
hsdR hsdM recAl (1) was used for all of the transformation and plas-
mid studies.
levels were analyzed from lysates of cells grown in liquid
cultures before and several hours after a shift to the restric-
tive temperature. Although this analysis was somewhat com-
plicated by the similarity in molecular weights of pMB9 and
pJN75, we were still able to observe that with pMB9 present
in the cell, there was very little temperature-induced amplifi-
cation of pJN75 DNA (data not shown). Suppression of the
conditional lethal phenotype of pJN75 was also observed
with the pMB1 derivatives, pBR322 and pBR325 (Table 2).
The electrophoretogram shown in Fig. 2 illustrates the effect
of a plasmid derived from pBR325 on the temperature-in-
duced amplification of pJN75 DNA.
NTP1 is compatible with pMB1-derived plasmids-i.e.,
NTP1 and pMB1 derivatives can stably coexist in the same
cell. This is apparently a consequence of the fact that the
RNA I species encoded by NTP1 is not identical to the
pMB1 RNA I species. In vitro experiments described by To-
mizawa and Itoh (7) indicate that purified NTP1 (RSF1030)
RNA I does not inhibit primer formation of a ColEl template
Table 2. trans-suppression of pJN75 runaway replication by
various compatible plasmids
Presence Suppression of ts
Incompatibility of rop lethal phenotype of
Plasmid class gene pJN75-containing cells
pMB9 pMB1 + +
pBR322 pMB1 + +
pBR325 pMB1 + +
pAT153 pMB1 - -
pKO1 pMB1 - -
pUC8 pMB1 -
pACYC184 pl5A (-)?
pDM254 plSA, pMB1 (-)? -
E. coli HB101 cells containing pJN75 were transformed with the
indicated plasmids following the transformation procedure of Dagert
and Ehrlich (17). Cells were spread onto L plates containing ampicil-
lin (50 ,ug/ml), which were then incubated overnight at 42°C. Plas-
mids that produced temperature-resistant colonies with a high trans-
formation efficiency (>106 per ,g of plasmid DNA) are indicated by
a + sign. A - sign indicates those plasmids that did not give tem-
perature-resistant colonies. Plasmids pMB9, pBR322, and pBR325
are all pMB1 derivatives that contain the region of the plasmid
genome encoding the rop gene. Plasmid pAT153 (3) is identical to
pBR322 except for deletion of a 622-bp Hae II restriction fragment
that contains the entire rop gene (4). Plasmids pKO1 (18) and pUC8
(19) are also derived from pBR322 and contain only the portion of
the rop gene that codes for the last 9 amino acids of the 63 amino
acid polypeptide. Plasmid pACYC184 contains the replication origin
from plSA (20). There is no evidence of a rop gene encoded on
pACYC184 or plSA. Plasmid pDM254 (8) is a pACYC184 derivative
with four copies of the pMB1-RNA I gene cloned in tandem at the
BamHI site.
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FIG. 2. Suppression of temperature-induced amplification of
pJN75 DNA by a pMB1 derivative carrying the rop gene. HB101
cells carrying either pJN75 (ampicillin resistant) or pJN75 and plas-
mid pAC16 (tetracycline resistant, chloramphenicol resistant) were
grown in L broth containing the appropriate antibiotics at 30'C to an
A590 of 0.15. Half of each culture was then transferred to 370C and all
cultures were incubated for an additional 3 hr. A portion of each
culture was then mixed with a portion of another cell culture con-
taining an equal number of HB101 cells carrying plasmid pKO1 (18).
The pKO1-containing cells were added immediately prior to cell har-
vest to provide a control plasmid for standardizing plasmid DNA
recoveries. After harvesting by centrifugation, the cells were lysed
and total plasmid DNA was isolated as described (8). The covalently
closed circular plasmids were analyzed by electrophoresis through a
L.0o agarose gel. Plasmid pAC16 (23) is a pBR325 derivative that
contains a 700-bp rat actin cDNA insert cloned into the Pst I site and
therefore does not confer ampicillin resistance to its host.
and that ColEl RNA I does not inhibit NTP1 primer forma-
tion. Since there is apparently no cross-inhibition of plasmid
replication by the two wild-type RNA I species, we speculat-
ed that a negative control element other than RNA I was
responsible for the suppression of pJN75 replication by the
pMB1 derivatives. The inability of plasmid pDM254 (8),
which contains multiple pMB1 RNA I genes, to suppress
pJN75 runaway replication supports this notion (Table 2).
Since the pMB1 derivatives that provide suppressor activity
also encode the rop gene described by Cesareni et al. (4), the
rop gene product seemed a likely candidate for the trans-
acting suppressor. Therefore, we looked at the effect of co-
cultivation of pJN75 with several pMB1-derived plasmids
that contained deletions of all or part of the rop gene (Table
2). No suppression was observed with the pBR322 derivative
pAT153, -pKO1, or pUC8. Plasmid pAT153 differs from
pBR322 by a deletion of the 622-bp Hae II restriction frag-
ment that encodes the entire rop gene. Plasmids pKO1 and
pUC8 contain a deletion of the 3' end of the rop gene. These
results imply that the rop gene product is responsible for the
suppression of the runaway replication phenotype of pJN75.
Isolation of Mutant Derivatives of pJN75 Insensitive to rop
Suppression. These observations suggested a way to identify
the site where rop interacts in suppressing pJN75 runaway
replication-namely, by isolating mutants of pJN75 that are
insensitive to rop-mediated suppression. The rationale for
selecting such mutants depends on the idea that, at tempera-
tures intermediate between permissive (30°C) and nonper-
missive (37°C), the copy number of the mutant plasmid
should be elevated but not lethal to the cells. To test this
idea, cells carrying pJN70 or pJN75 were plated at 34°C on L
agar plates containing a high concentration of ampicillin (4
mg/ml). As expected, cells carrying pJN75 were able to
grow because the copy number was high, whereas cells car-
rying the wild-type plasmid did not produce enough P-lacta-
mase to survive. Furthermore, cells carrying pJN75 plus
pMB9 did not form colonies under these conditions, because
rop-mediated suppression of pJN75 replication reduces the
copy number to a level below what is required to confer
resistance to ampicillin at 4 mg/ml (Table 2). To isolate a
rop-insensitive plasmid, mutagenized pJN75 DNA was used
to transform cells that contained pMB9 at 34TC. Only pJN75
derivatives insensitive to replication inhibition by rop func-
tion were expected to grow. Several such colonies were iso-
lated and shown to retain the ts lethal phenotype at 420C,
indicating that the original mutation in pJN75 was still pres-
ent. Seven of the colonies able to grow at 34TC but not at
42TC were selected for further characterization. Analysis of
the DNA content of these cells revealed that both plasmids
(pMB9 and the pJN75 derivative) were present as mono-
mers, suggesting the phenotype was due to a mutation of the
pJN75 genome. The plasmids exhibiting the non-suppressed
phenotype in the presence of rop were designated pJN75nsr
for nonsuppressible by rop.
Mapping of the nsr Mutations. The nucleotide sequence
surrounding the replication origin of the nsr derivatives of
pJN75 was determined following the procedure of Maxam
and Gilbert (21). Each of the mutant plasmids was found to
contain the original pJN75 alteration and a single additional
base pair change within the 800-bp region extending from 100
bp downstream of the origin of DNA synthesis to 700 bp
upstream of the origin. One of the mutants contained a G-C
to A-T transition at position -439 (nsrl). (Position + 1 is de-
fined as the site of incorporation of the first deoxynucleotide
during the initiation of plasmid DNA replication.) Five other
mutants contained a G&C to A.T transition 10 bp away at po-
sition -449 (nsr2). An additional mutant appeared at -430
(nsr3). All of these mutations cause disruption of base-pair-
ing within the stem of loop-structure III in the primer tran-
script and loop-structure III' of RNA I (Fig. 3). This result is
consistent with the galK fusion studies of Som and To-
mizawa (5), which indicate that sequences important for rop
function do not fall in the promoter for RNA II, but instead
lie further downstream. The mutations we have identified
define this region to be within the coding sequnce for both
RNA I and RNA II, near the 5' terminus of RNA I.
DISCUSSION
In this paper we have shown that the rop gene provides a
trans-acting function that can suppress runaway replication
of the NTP1 ts copy-number mutant pJN75. This conclusion
is based on the observation that plasmids with deletions of
part or all of the rop gene lack the suppressor activity. This
interpretation is also supported by previous reports that the
rop gene acts in trans to lower plasmid copy number (3, 5).
We have used the ability of the rop gene product to suppress
the ts lethal phenotype of the runaway replication mutant
pJN75 to further investigate the general mechanism' by
which rop modulates plasmid copy number. Although the
molecular details of this inhibition are not yet understood,
one model has been that the rop gene product may be inhibit-
ing transcription of RNA II and therefore controlling replica-
tion by limiting the amount of precursor RNA available for
primer formation. This idea is supported by the observations
of Cesareni et al. (4) and Som and Tomizawa (5) that the rop
gene product inhibits production of 0-galactosidase or galac-
tokinase when the lacZ or galK genes are fused to the primer
downstream of the primer promoter.
To investigate how such inhibition might occur, we looked
for mutants resistant to inhibition by the rop gene product as
described above. We have identified mutants of pJN75 des-
ignated nsr, which express the lethal runaway replication
phenotype at 42°C even in the presence of the rop gene en-
coded on a second plasmid in the cell. The nucleotide se-
quence of seven nsr plasmids revealed that none of the muta-
tions falls within the promoter for RNA II, as might have
been expected from the model just described. The mutations
disrupt base pairs within stem-loop structure III (see Fig. 3)
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FIG. 3. RNA I transcript from plasmid pJN75. Mutations nsrl, nsr2, and nrs3 are those identified within the mutant pJN75 derivatives that
were selected by their ts phenotypes in the presence of pMB9. The RNA I secondary structure shown is that proposed by Som and Tomizawa
(6) based on the secondary structure of ColEl RNA I proposed by Morita and Oka (24).
present in both RNA I and RNA II. It is perhaps worth not-
ing that the two nucleotide pairs affected by the mutations
nsrl and nsr2 are conserved in the RNA I species from
ColEl, pl5A, RSF1030, and CloDF13 (25). In addition, on
the same stem structure immediately adjacent to these
paired bases is an unpaired nucleotide that is also conserved
in these plasmids. It is imaginable that this "spur" on the
stem could be a part of a recognition site for the binding of a
small protein. Our findings, along with those of Som and To-
mizawa (5), that a region within the coding sequence ofRNA
II, rather than in the primer promoter, was necessary for
inhibition suggests that the rop protein does not act by bind-
ing to an operator site near or within the promoter and com-
peting with RNA polymerase binding. This is also consistent
with the fact that the rop protein from pMB1 can inhibit rep-
lication of plasmids such as NTP1, which have virtually no
sequence homology to pMB1 in the DNA immediately 5' to
the primer RNA, in the primer promoter.
Som and Tomizawa (5) have recently suggested that the
rop protein enhances hybrid formation between RNA I and
its complementary region ofRNA II. Our results are consist-
ent with, though by no means prove, this interpretation, in
that all of the.nsr mutations fall in the region of RNA I and
RNA II overlap. Thus, one possibility is that the rop protein
may recognize one or more of the stem-loop structures on
either RNA I or RNA II and bind them. Binding of the rop
protein might then favor the interaction of RNA I and its
target region of RNA II.
However, there is one important caveat in interpreting the
nsr mutations as identifying a rop-nucleic acid interaction
site. Analysis of the nsr mutations is complicated by the fact
that the rop-insensitive mutations described here may also
alter the structure ofRNA I or RNA II such that the inherent
ability of these RNAs to interact with each other is dimin-
ished. In other words, an altered copy-number phenotype
associated with a mutation in the RNA I coding region can
be a consequence of either a defective (unstable) RNA I in-
hibitor, an altered RNA I target site within the primer tran-
script, increased RNA II transcription, or the inability of the
rop protein to interact with either of the mutant transcripts.
It is quite likely that all of these functions could be affected
by a single point mutation. The mutation nsrl that we have
identified affects a nucleotide at the same position in pJN75
RNA I as the svirl9 mutation of pMB1 described by Laca-
tena and Cesareni (10). The latter mutation' was obtained by
using a "phasmid" selection designed to isolate mutants ex-
hibiting reduced sensitivity to the wild-type replication in-
hibitor RNA I. When released from the X chromosome, the
mutant plasmid containing the svirl9 mutation was lethal for
the host cell. We have also found that nsrl and nsr2 mutants
are lethal to the host cell in the absence of pMB9 or other
compatible rop+ plasmids (data not shown). This lethality is
independent of temperature and is assumed to result from
uncontrolled or runaway plasmid replication, although this
has not been demonstrated either for svirl9 or for the nsr
mutants. Thus, nsrl and nsr2 appear to retain at least some
sensitivity to rop protein. These results are consistent with
the possibility that the mutations nsrl and nsr2 in NTP1 and
svirl9 in pMB1 affect both the RNA I-RNA II interaction
and the rop protein function. The rop protein may enhance
the hybridization of the two RNAs as proposed by Som and
Tomizawa (5). However, the possibility that rop may affect
transcription or stability of RNA II or stability of RNA I is
not ruled out by our data.
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